ClinicalTrials.Veeva

Menu

Adjunct Inversion for Lower Pole Stone

M

Monash University

Status

Completed

Conditions

Kidney Stone

Treatments

Procedure: Shock Wave Lithotripsy
Procedure: Inversion
Drug: Hydration

Study type

Interventional

Funder types

Other

Identifiers

Details and patient eligibility

About

This is a randomized controlled trial comparing extracorporeal shockwave lithotripsy (ESWL) with and without simultaneous adjunct controlled inversion therapy in the treatment of lower pole caliceal stone.

Enrollment

140 patients

Sex

All

Ages

18 to 75 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  1. Solitary lower pole caliceal stone which is > 5 mm and < 20mm
  2. Not contraindicated for intravenous urogram (IVU) and subsequent X-rays
  3. Patient able to comply strictly with visits/medications
  4. Patient willing and agrees to enter study

Exclusion criteria

  1. Impaired function of the affected kidney
  2. Gross hydronephrosis of the affected kidney
  3. Associated distal obstruction
  4. Multiple stones
  5. Stone more than 2 cm in size
  6. Diverticular stone
  7. Patients who are contraindicated for extracorporeal shockwave lithotripsy e.g.: Pregnancy
  8. Patients who are unable to tolerate the procedure
  9. Significant cardiac condition that does not allow the administration of force hydration or inversion.
  10. Uncontrolled hypertension

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Double Blind

140 participants in 2 patient groups

Inversion, Hydration, ESWL
Experimental group
Description:
ESWL with hydration and inversion
Treatment:
Procedure: Inversion
Drug: Hydration
Procedure: Shock Wave Lithotripsy
ESWL, Hydration
Active Comparator group
Description:
ESWL with hydration
Treatment:
Drug: Hydration
Procedure: Shock Wave Lithotripsy

Trial contacts and locations

0

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems